On November 30, 2022, the United States Court of Appeals for the Third Circuit revived a quality control manager’s FCA retaliation claim in United States ex rel. Ascolese v. Shoemaker.
In a rare action by the Supreme Court of the United States, Chief Justice Roberts granted Novartis's emergency request for a stay of a mandate from the US Court of Appeals.
Chief Justice Roberts granted Novartis’s emergency request for a stay of a mandate from US Court of Appeals for the Federal Circuit, which found a Novartis patent invalid for lack of adequate written description and permitted production of generic versions of drug Gilenya.
In a rare action by the Supreme Court of the United States, Chief Justice Roberts granted Novartis’s emergency request for a stay of a mandate from the US Court of Appeals for the.